Clinical Trials Browser

Phase 2 × Lymphoma, Extranodal NK-T-Cell × Radiotherapy, Intensity-Modulated × Clear all

NCT02276248 2017-08-16

Radiotherapy Combined With GDP Chemotherapy in Stage I/II Extranodal Natural Killer/T-cell Lymphoma

Phase 2 Completed

Lymphoma, Extranodal NK-T-Cell

NCT02808091 2016-09-05

Gifox-B

Phase 2 Terminated

Lymphoma, Extranodal NK-T-Cell